Advisor Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $154K | Sell |
2,377
-1,105
| -32% | -$71.6K | ﹤0.01% | 2601 |
|
|
2019
Q3 | $217K | Sell |
3,482
-2,435
| -41% | -$152K | ﹤0.01% | 2260 |
|
|
2019
Q2 | $421K | Buy |
5,917
+133
| +2% | +$9.46K | ﹤0.01% | 1737 |
|
|
2019
Q1 | $454K | Sell |
5,784
-238
| -4% | -$18.7K | ﹤0.01% | 1662 |
|
|
2018
Q4 | $511K | Sell |
6,022
-4,617
| -43% | -$392K | 0.01% | 1394 |
|
|
2018
Q3 | $1.82M | Sell |
10,639
-119
| -1% | -$20.4K | 0.02% | 680 |
|
|
2018
Q2 | $1.39M | Buy |
10,758
+6,143
| +133% | +$794K | 0.02% | 708 |
|
|
2018
Q1 | $475K | Buy |
4,615
+2,879
| +166% | +$296K | 0.01% | 1356 |
|
|
2017
Q4 | $148K | Sell |
1,736
-13
| -0.7% | -$1.11K | ﹤0.01% | 2248 |
|
|
2017
Q3 | $149K | Sell |
1,749
-50
| -3% | -$4.26K | ﹤0.01% | 2078 |
|
|
2017
Q2 | $136K | Sell |
1,799
-93
| -5% | -$7.03K | ﹤0.01% | 2065 |
|
|
2017
Q1 | $125K | Sell |
1,892
-36
| -2% | -$2.38K | ﹤0.01% | 2014 |
|
|
2016
Q4 | $122K | Sell |
1,928
-4,604
| -70% | -$291K | ﹤0.01% | 1933 |
|
|
2016
Q3 | $416K | Buy |
6,532
+1,340
| +26% | +$85.3K | 0.01% | 1075 |
|
|
2016
Q2 | $385K | Buy |
+5,192
| New | +$385K | 0.01% | 1051 |
|